ADVERTISING MIND-ALTERING SUBSTANCES
It is a well-known rule of thumb in business: 80% of your sales come from 20% of your clients. It applies to hardware stores, new car sales and designer clothing sales. It also applies to the subject of drug abuse, excessive drinking and addiction.
New reports show the club drug ketamine, also known as “Special K,” may be used to treat severe depression. But is it such a good idea to push a drug to treat depression when that drug has a long history of being addictive, mind-altering, and potentially quite harmful?
A recent study found that despite billions of dollars spent annually on marketing and ad buys, most pharmaceutical drugs don’t work that well on patients who take them.
Though alcohol is legal for adults 21 and older, alcohol is not a safe or healthy substance to consume. Case in point, new research shows how a particular type of alcohol is particularly appealing to and dangerous for… underage drinkers.
A 2019 study draws a connection between medical marijuana advertising and adolescent marijuana use. According to the study, in regions where medical marijuana is heavily promoted, there is more youth cannabis use. If this correlation is true, residents should take a stand against medicinal marijuana advertisements immediately.
Remarkably, Lithuania’s alcohol-related vehicle fatalities decreased 82% during a 15-year long experimental phase in which alcohol-related restrictions were imposed on the general public (especially those driving while intoxicated). Should we consider cracking down more on not only drunk driving but also on the circumstances that precipitate drunk driving?